Holen Sie sich die Stockscreener-App
1.72
4.24%
0.07
Handel nachbörslich:
1.72
Schlusskurs vom Vortag:
$1.65
Offen:
$1.66
24-Stunden-Volumen:
265.44K
Relative Volume:
0.66
Marktkapitalisierung:
$83.20M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.0853
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
+9.55%
1M Leistung:
+14.67%
6M Leistung:
-33.85%
1J Leistung:
-81.97%
1-Tages-Spanne:
$1.60
$1.75
1-Wochen-Bereich:
$1.565
$1.755
52-Wochen-Spanne:
$1.38
$10.76
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.72 | 75.97M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Cibus Inc. Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com
What analysts say about Cibus Inc. stockFree Trend-Following Techniques - jammulinksnews.com
Is Cibus Inc. a good long term investmentExtraordinary profit generation - printweek.in
What drives Cibus Inc. stock priceOverwhelming profit margins - Autocar Professional
Cibus Inc. shares fall 4.76% after-hours despite Pareto Securities raising price target to SEK 215. - AInvest
What makes Cibus Inc. stock price move sharplySteady Profit Stock Forecasts - beatles.ru
Cibus Inc. shares rise 1.22% after-hours after acquiring ten properties for over SEK 400 million. - AInvest
How Cibus Inc. stock performs during market volatilityPredictable Return Stock Picks - Newser
Why Cibus Inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser
Cibus (NASDAQ:CBUS) & Cadiz (NASDAQ:CDZI) Head to Head Survey - Defense World
US FDA Completes Review of Altered Lignin Alfalfa Developed by Cibus and S&W Seed - ISAAA.org
Cibus, Inc.(NasdaqCM: CBUS) dropped from Russell 3000E Index - MarketScreener
FDA completes review of altered lignin alfalfa - Agri-Pulse
First Gene-Edited Alfalfa Gets FDA Green Light: Cibus Ready for Commercial Launch - Stock Titan
Cibus and John Innes Centre announce ongoing collaboration with potential to revolutionise fertilizer use in farming - World Fertilizer
Financial Metrics Exploration: Understanding Cibus Inc (CBUS) Through Ratios - DWinneX
Two Sigma Investments LP Purchases New Holdings in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus Slides on Alliance with John Innes Centre - Baystreet.ca
Cibus (CBUS) Expands Collaboration with John Innes Centre for Cr - GuruFocus
Cibus (CBUS) Expands Collaboration with John Innes Centre for Crop Innovation | CBUS Stock News - GuruFocus
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming - The Manila Times
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize ... - Leader-Telegram
Agricultural Breakthrough: Scientists Find Gene Mutation That Could Transform Farming Economics - Stock Titan
USDA-APHIS Designates Cibus's Herbicide Tolerance Canola Trait HT2 as Not Regulated - ISAAA.org
Millennium Management LLC Sells 15,409 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus, Inc. Announces Closing of $27.5 Million Public Offering - The Manila Times
Cibus, Inc. Announces Closing of $27.5 Million Public Offering | - GuruFocus
Cibus, Inc. Closes $27.5 Million Public Offering of Class A Common Stock - Nasdaq
Agricultural Biotech Cibus Secures $27.5M Investment to Advance Gene Editing Platform - Stock Titan
CBUS ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cibus, Inc. Shareholders Who Lost Money - ACCESS Newswire
Hogs Look to New Week Following Friday Strength - The Globe and Mail
Jane Street Group LLC Takes Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus says USDA designates HT2 as ‘not regulated’ under biotech regulations - Yahoo Finance
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):